Trials / Recruiting
RecruitingNCT02738047
Reduction of Adverse Drug Events and Readmissions
Pharmacogenomic Test Assessment for Medication Management in the Advancement of Medicine
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 280,000 (estimated)
- Sponsor
- ClinLogic LLC · Industry
- Sex
- All
- Age
- 25 Years
- Healthy volunteers
- Accepted
Summary
Pharmocogenomic test assessment in the medication regimen and disease management for patients under drugs known with genetic variation.
Detailed description
Pharmocogenomic. A multicenter, observational study to evaluate the use of a Pharmocogenomic test assessment in the medication regimen and disease management for patients under drugs known to be influenced by genetic variation.
Conditions
Timeline
- Start date
- 2019-03-15
- Primary completion
- 2025-03-01
- Completion
- 2026-12-01
- First posted
- 2016-04-14
- Last updated
- 2024-02-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02738047. Inclusion in this directory is not an endorsement.